These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23388422)

  • 1. Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis.
    Bower M; Wunderlich C; Brown R; Scoggins CR; McMasters KM; Martin RC
    Am J Surg; 2013 Jun; 205(6):685-90. PubMed ID: 23388422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.
    Pathak S; Tang JM; Terlizzo M; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2010 Jan; 36(1):52-7. PubMed ID: 19879103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?
    Abdalla EK; Vauthey JN
    Dig Surg; 2008; 25(6):421-9. PubMed ID: 19212114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.
    Brouquet A; Benoist S; Julie C; Penna C; Beauchet A; Rougier P; Nordlinger B
    Surgery; 2009 Apr; 145(4):362-71. PubMed ID: 19303984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: preliminary results of a case-control study.
    Pessaux P; Panaro F; Casnedi S; Zeca I; Marzano E; Bachellier P; Jaeck D; Chenard MP
    Eur J Surg Oncol; 2010 Jun; 36(6):575-82. PubMed ID: 20452168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive factors for histopathological liver injury in the patients who received preoperative systemic chemotherapy for colorectal liver metastases].
    Kudo D; Tsutsumi S; Akasaka H; Jin H; Ohashi T; Muroya T; Hasebe T; Sakamoto Y; Ishido K; Koyama M; Toyoki Y; Murata A; Narumi S; Kijima H; Hakamada K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2025-7. PubMed ID: 20037312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
    J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
    Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
    Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.
    Vauthey JN; Pawlik TM; Ribero D; Wu TT; Zorzi D; Hoff PM; Xiong HQ; Eng C; Lauwers GY; Mino-Kenudson M; Risio M; Muratore A; Capussotti L; Curley SA; Abdalla EK
    J Clin Oncol; 2006 May; 24(13):2065-72. PubMed ID: 16648507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
    Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
    HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
    Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F
    Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection.
    O'Rourke TR; Welsh FK; Tekkis PP; Lyle N; Mustajab A; John TG; Peppercorn D; Rees M
    Eur J Surg Oncol; 2009 Oct; 35(10):1085-91. PubMed ID: 19246171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
    Ryan P; Nanji S; Pollett A; Moore M; Moulton CA; Gallinger S; Guindi M
    Am J Surg Pathol; 2010 Jun; 34(6):784-91. PubMed ID: 20421779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced steatohepatitis in colorectal cancer patients.
    Gentilucci UV; Santini D; Vincenzi B; Fiori E; Picardi A; Tonini G
    J Clin Oncol; 2006 Dec; 24(34):5467; author reply 5467-8. PubMed ID: 17135651
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis.
    Urdzik J; Bjerner T; Wanders A; Weis J; Duraj F; Haglund U; Norén A
    J Hepatol; 2012 Mar; 56(3):640-6. PubMed ID: 22027576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
    Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
    Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.